2026-07-29 16:34:30 UTC / 路透社
独家报道
美国联邦贸易委员会起诉Hims & Hers，指控其向Meta、Snap泄露用户健康信息
作者：乔迪·戈多伊
2026年7月29日 下午4:34 UTC，更新于45分钟前
公司相关
Hims & Hers Health Inc 关注
Snap Inc 关注
Meta Platforms Inc 关注
显示更多公司
7月29日（路透社）——美国联邦贸易委员会周三起诉远程医疗平台Hims & Hers（纽约证券交易所代码：HIMS.N，打开新标签页），指控该平台尽管承诺保护用户隐私，却仍将用户健康数据分享给在线广告商，同时还存在欺骗性收费和取消订阅的违规行为。
联邦贸易委员会在与洛杉矶县和犹他州联合提起的诉讼中指控称，尽管该公司让客户相信其数据受到隐私保护，但仍将用户的敏感健康信息分享给了包括Meta Platforms（纽约证券交易所代码：META.O，打开新标签页）和Snap（纽约证券交易所代码：SNAP.N，打开新标签页）在内的在线广告公司。
路透社每日简报通讯为您提供开启一天所需的全部新闻。点击此处订阅。
广告 · 滚动继续
消息公布后，Hims & Hers的股价进一步下跌，当日交易时段跌幅约12%。
Hims & Hers是美国减肥药物市场上规模最大的远程医疗服务商之一。该公司提供远程医疗问诊服务，并开具勃起功能障碍、脱发和心理健康药物的处方，直接配送给客户。
“联邦贸易委员会将毫不犹豫地代表那些被剥夺了选择产品权利，以及无法决定是否将自身最敏感健康信息保密的消费者采取行动，”美国联邦贸易委员会消费者保护局局长克里斯托弗·穆法里格在一份声明中表示。
广告 · 滚动继续
Hims & Hers在社交媒体平台X上的发帖中称这些指控毫无根据。“这并非基于消费者保护的执法行动；这是一则试图以牺牲我们为代价制造头条新闻的行为，”该公司在帖子中说道。
联邦贸易委员会还指控，Hims & Hers在用户尚未有机会与医疗服务提供者面诊之前，就开始向用户收取处方费用。
据该机构称，大多数客户并未与医疗服务提供者进行面诊，而是在填写完 intake 表格后很快就被收取了处方费用。
联邦贸易委员会表示，Hims & Hers还设置障碍，让用户难以取消订阅服务。
blob:https://www.reuters.com/0aa327f9-e278-4fdc-b552-2472bc2bdd55
本报纽约记者乔迪·戈多伊报道；编辑：千住博美（音译）和克里斯·桑德斯
我们的报道准则：路透社汤森路透信任原则，打开新标签页
By Jody Godoy
July 29, 2026 4:34 PM UTC Updated 45 mins ago
The New York Stock Exchange with a Hims & Hers Health, Inc banner is pictured as a person runs past in the Manhattan borough of New York City, New York, U.S., January 21, 2021. REUTERS/Carlo Allegri/File Photo Purchase Licensing Rights, opens new tab
Companies
Hims & Hers Health IncFollow
Snap IncFollow
Meta Platforms IncFollow
Show more companies
July 29 (Reuters) – The U.S. Federal Trade Commission sued, opens new tab Hims & Hers (HIMS.N), opens new tab on Wednesday alleging the telehealth platform shared users’ health data with online advertisers, despite promising privacy, and engaged in deceptive billing and cancellation practices.
Users’ sensitive health information was shared with online advertising companies including Meta Platforms (META.O), opens new tab and Snap (SNAP.N), opens new tab despite the company leading customers to believe their data was private, the FTC alleged in the lawsuit filed along with Los Angeles County and Utah.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
Advertisement · Scroll to continue
Hims & Hers stock added to losses after the news and was trading down around 12%.
Hims & Hers is one of the largest telehealth players in the market for weight loss drugs. The company offers telehealth appointments and prescriptions for erectile dysfunction, hair loss, and mental health medications, which it ships straight to customers.
“The FTC will not hesitate to act on behalf of consumers deprived of their ability to choose which products they want and whether to keep their most sensitive health information private,” Christopher Mufarrige, Director of the FTC’s Bureau of Consumer Protection, said in a statement.
Advertisement · Scroll to continue
Hims & Hers called the claims baseless in a post on social media site X. “This is not enforcement grounded in consumer protection; it is an effort to generate headlines at our expense,” the company said in the post.
Hims & Hers also started charging users for prescriptions before they have had a chance to meet with healthcare providers, the FTC alleged.
Most customers do not receive a consultation with a provider, and instead are charged for prescriptions soon after filling out an intake form, according to the agency.
Hims & Hers also makes it difficult to cancel subscriptions, the FTC said.
blob:https://www.reuters.com/0aa327f9-e278-4fdc-b552-2472bc2bdd55
Reporting by Jody Godoy in New York; Editing by Chizu Nomiyama and Chris Sanders
Our Standards: The Thomson Reuters Trust Principles., opens new tab
发表回复